EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

The use of LNG-IUS-19.5 mg in daily gynecological routine practice in Germany: data from the Kyleena™ Satisfaction Study (KYSS)

Thomas Römer, Ann-Kathrin Frenz, Susanne Dietrich-Ott, Anja Fiedler

Archives of Gynecology and Obstetrics · 29.02.2024 · 309 (5) · 2021-2030

DOI: 10.1007/s00404-024-07421-5 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Archives of Gynecology and Obstetrics, online erschienen am 29.02.2024. Verfasst von Thomas Römer und 3 weiteren Autor:innen. Beteiligte Einrichtung: Obstetrics and Gynecology Department, Academic Hospital Weyertal, University of Cologne, Cologne, Germany. Thomas.Roemer@evk-koeln.de. Hauptthemen laut MEDLINE: Contraceptive Agents, Female, Intrauterine Devices, Medicated. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bayer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The Kyleena™ Satisfaction Study (KYSS) provided the first data on 19.5 mg levonorgestrel-releasing intrauterine system (LNG-IUS-19.5 mg) use in routine clinical practice. Here we report results from the German participants in KYSS.

Methods

This prospective, observational, single-arm cohort study recruited women who independently chose to use LNG-IUS-19.5 mg during routine counseling in Germany. Overall satisfaction and bleeding profile satisfaction, continuation rates, and safety profile were evaluated at 12 months or premature end of observation (EoO).

Results

In the German study population, LNG-IUS-19.5 mg placement was attempted in 508 women and successful in 506 women. Mean age was 32.3 years, and 60.0% (n = 305/508) were parous. Placement was considered easy and associated with no more than mild pain, even in younger and nulliparous participants. Of those with satisfaction data available, 87.6% (n = 388/443) were satisfied with LNG-IUS-19.5 mg at 12 months/EoO. Satisfaction was similar for parous (86.9%, n = 238/274) and nulliparous (88.8%, n = 150/169) women, and was independent of age, prior contraceptive method, or reason for choosing LNG-IUS-19.5 mg. Most participants (73.6%, n = 299/406) were also satisfied with their bleeding profile at 12 months/EoO, independent of parity, age, prior contraceptive method, presence of amenorrhea or dysmenorrhea severity. The 12-month continuation rate was 84.1% (n = 427/508). Most discontinuations were due to loss to follow-up (8.5%, n = 43/508) or treatment-emergent adverse events (TEAEs) (4.7%, n = 24/508). TEAEs were reported in 12.6% (n = 64) of participants, with 9.3% (n = 47) considered to have an LNG-IUS-19.5 mg-related TEAE.

Conclusion

Our real-world findings on LNG-IUS-19.5 mg use in German KYSS participants reflected its suitability for a broad population, including young and nulliparous women. Clinical trial registration NCT03182140 (date of registration: June 2017).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Contraceptive Agents, FemaleIntrauterine Devices, MedicatedPregnancyFemaleHumansAdultLevonorgestrelProspective StudiesCohort StudiesGermanyDysmenorrhea

Stichwörter der Autor:innen

ContraceptionContraceptive safetyLevonorgestrel-releasing intrauterine systemLong-acting reversible contraceptiveLow-dose intrauterine systemSatisfaction

Substanzen

LevonorgestrelContraceptive Agents, Female

Autor:innen und Institutionen

  • Obstetrics and Gynecology Department, Academic Hospital Weyertal, University of Cologne, Cologne, Germany. Thomas.Roemer@evk-koeln.de.
  • Medical Affairs, Bayer AG, Berlin, Germany.
  • Jenapharm GmbH & Co. KG, Jena, Germany.
  • Medical Practice of Obstetrics and Gynecology, Gera/Jena, Germany.

Förderung

  • Bayer

Zitieren

APA

Römer, T., Frenz, A. K., Dietrich-Ott, S., & Fiedler, A. (2024). The use of LNG-IUS-19.5 mg in daily gynecological routine practice in Germany: data from the Kyleena™ Satisfaction Study (KYSS). Archives of Gynecology and Obstetrics, 309(5), 2021-2030. https://doi.org/10.1007/s00404-024-07421-5

Vancouver

Römer T, Frenz AK, Dietrich-Ott S, Fiedler A. The use of LNG-IUS-19.5 mg in daily gynecological routine practice in Germany: data from the Kyleena™ Satisfaction Study (KYSS). Archives of Gynecology and Obstetrics. 2024;309(5):2021-2030. doi:10.1007/s00404-024-07421-5

BibTeX
@article{Rmer2024,
  author = {Römer, Thomas and Frenz, Ann-Kathrin and Dietrich-Ott, Susanne and Fiedler, Anja},
  title = {The use of LNG-IUS-19.5 mg in daily gynecological routine practice in Germany: data from the Kyleena™ Satisfaction Study (KYSS)},
  journal = {Archives of Gynecology and Obstetrics},
  year = {2024},
  volume = {309},
  number = {5},
  pages = {2021--2030},
  doi = {10.1007/s00404-024-07421-5}
}
Kostenlos starten →